Sandoz Group AG (SDZXF)

OTCMKTS · Delayed Price · Currency is USD
88.00
-6.55 (-6.93%)
At close: Feb 27, 2026
95.82%
Market Cap 38.28B
Revenue (ttm) 11.16B
Net Income (ttm) 914.00M
Shares Out n/a
EPS (ttm) 2.09
PE Ratio 41.88
Forward PE 21.93
Dividend 0.73 (0.84%)
Ex-Dividend Date Apr 17, 2025
Volume 611
Average Volume 3,021
Open 88.00
Previous Close 94.55
Day's Range 88.00 - 88.00
52-Week Range 36.68 - 94.55
Beta 0.26
RSI 66.39
Earnings Date Feb 25, 2026

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland. [Read more]

Sector Healthcare
Founded 1886
Employees 20,000
Stock Exchange OTCMKTS
Ticker Symbol SDZXF
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.